Contemporary surgical treatment of benign prostatic hyperplasia
- PMID: 28977110
- DOI: 10.1590/1806-9282.63.08.711
Contemporary surgical treatment of benign prostatic hyperplasia
Abstract
Benign prostatic hyperplasia (BPH) is a common condition in adult men and its incidence increases progressively with aging. It has an important impact on the individual's physical and mental health and its natural progression can lead to serious pathological situations. Although the initial treatment is pharmacological, except in specific situations, the tendency of disease progression causes a considerable portion of the patients to require surgical treatment. In this case, there are several options available today in the therapeutic armamentarium. Among the options, established techniques, such as open surgery and endoscopic resection using monopolar energy, still prevail in the choice of surgeons because they are more accessible, both from a socioeconomic standpoint in the vast majority of medical services and in terms of training of medical teams. On the other hand, new techniques and technologies arise sequentially in order to minimize aggression, surgical time, recovery and complications, optimizing results related to the efficacy/safety dyad. Each of these techniques has its own peculiarities regarding availability due to cost, learning curve and scientific consolidation in order to achieve recognition as a cutting-edge method in the medical field. The use of bipolar energy in endoscopic resection of the prostate, laser vaporization and enucleation techniques, and videolaparoscopy are examples of new options that have successfully traced this path. Robot-assisted surgery has gained a lot of space in the last decade, but it still needs to dodge the trade barrier. Other techniques and technologies will need to pass the test of time to be able to conquer their space in this growing market.
Similar articles
-
Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.BJU Int. 2013 May;111(5):793-803. doi: 10.1111/j.1464-410X.2012.11730.x. Epub 2013 Mar 7. BJU Int. 2013. PMID: 23469933 Clinical Trial.
-
Trends and attitudes in surgical management of benign prostatic hyperplasia.Can J Urol. 2012 Apr;19(2):6170-5. Can J Urol. 2012. PMID: 22512959
-
Bipolar, Monopolar, Photovaporization of the Prostate, or Holmium Laser Enucleation of the Prostate: How to Choose What's Best?Urol Clin North Am. 2016 Aug;43(3):377-84. doi: 10.1016/j.ucl.2016.04.006. Urol Clin North Am. 2016. PMID: 27476130 Review.
-
Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).BJU Int. 2012 Dec;110(11 Pt C):E845-50. doi: 10.1111/j.1464-410X.2012.11290.x. Epub 2012 Jun 15. BJU Int. 2012. PMID: 22702908
-
[Old and new interventional therapies in the treatment of symptomatic benign prostate hyperplasia (BPH)].Ther Umsch. 2006 Feb;63(2):129-34. doi: 10.1024/0040-5930.63.2.129. Ther Umsch. 2006. PMID: 16514965 Review. German.
Cited by
-
Multicenter experience with photoselective vaporization of the prostate on men taking novel oral anticoagulants.Asian J Urol. 2020 Oct;7(4):340-344. doi: 10.1016/j.ajur.2019.07.005. Epub 2019 Jul 30. Asian J Urol. 2020. PMID: 32995278 Free PMC article.
-
Analysis of Present Status for Surgery of Benign Prostatic Hyperplasia in Korea Using Nationwide Healthcare System Data.Int Neurourol J. 2019 Mar;23(1):22-29. doi: 10.5213/inj.1836198.099. Epub 2019 Mar 31. Int Neurourol J. 2019. PMID: 30943691 Free PMC article.
-
Device Malfunctions and Complications Associated with Benign Prostatic Hyperplasia Surgery: Review of the Manufacturer and User Facility Device Experience Database.J Endourol. 2019 Jun;33(6):448-454. doi: 10.1089/end.2019.0067. Epub 2019 May 24. J Endourol. 2019. PMID: 30990073 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical